Peptides derived from a retrovirus of the HIV group, and their use

An immunologically active peptide comprising approximately 15 to 50 (pref. 20-30) consecutive amino acids (AA), selected from the sequence (I) is new:VWGIRQLRAR LQALETLIQN QQRLNLWGX KGKLIXYTSV KWNTSWSGR (I). In (I), X = C or S. Also claimed are: (a) the peptide produced either recombinantly or synth...

Full description

Saved in:
Bibliographic Details
Main Authors DR STEFAN BRUST, DR MANFRED GERKEN, PROFLUTZ G. GURTLER, DR STEFAN KNAPP
Format Patent
LanguageEnglish
Published 07.09.1995
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An immunologically active peptide comprising approximately 15 to 50 (pref. 20-30) consecutive amino acids (AA), selected from the sequence (I) is new:VWGIRQLRAR LQALETLIQN QQRLNLWGX KGKLIXYTSV KWNTSWSGR (I). In (I), X = C or S. Also claimed are: (a) the peptide produced either recombinantly or synthetically; (b) an isolated DNA fragment coding for a peptide as above; and (c) a test kit for the detection of viral antibodies causing immune deficiencies, pref. a Western Blot or an ELISA.
Bibliography:Application Number: AU19950013532